Previous close | 5.83 |
Open | 5.83 |
Bid | 5.20 |
Ask | 7.30 |
Strike | 25.00 |
Expiry date | 2024-09-20 |
Day's range | 5.83 - 5.83 |
Contract range | N/A |
Volume | |
Open interest | 14 |
SOUTH SAN FRANCISCO, Calif., May 06, 2024--14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients
SOUTH SAN FRANCISCO, Calif., April 22, 2024--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
SOUTH SAN FRANCISCO, Calif., April 22, 2024--New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance